Multi-Analyte Continuous Metabolic Sensing Market
完整報告名稱與涵蓋範圍
Multi-Analyte Continuous Metabolic Sensing Market Size, Share & Trends Analysis Report, By Analyte Combination (Glucose and Ketone Sensors, Glucose and Lactate Sensors, Multi-Analyte Panels (Glucose, Ketones, Lactate, Alcohol and Others), Implantable Long-Duration Multi-Analyte Sensors), By Sensor Platform (Enzymatic Electrochemical Microneedle and Filament Sensors, Optical and Fluorescence-Based Sensors, Emerging Non-Enzymatic and Aptamer-Based Platforms), By Application (Diabetes Management and Diabetic Ketoacidosis Prevention, Sports Performance and Metabolic Training, Critical Care and Clinical Monitoring, Metabolic Wellness and Nutrition), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The multi-analyte continuous metabolic sensing market covers wearable and implantable sensors that continuously measure two or more metabolic analytes such as glucose, ketones, lactate and alcohol, together with the sensor platforms, transmitters and software that support them, across diabetes management, sports performance, critical care and metabolic wellness. Single-analyte continuous glucose monitors are excluded from revenue but analysed as the platform base on which multi-analyte products build. Commercial products are few as of 2026, so forecast revenue is modelled from announced launch timelines and regulatory progress.
The leading glucose monitoring companies have announced dual glucose-ketone sensors that address diabetic ketoacidosis risk, a concern heightened by the use of SGLT2 inhibitors in type 1 diabetes and by ketogenic diets, and continuous lactate sensing targets athletes, critical care and sepsis monitoring. Microneedle and filament sensor arrays, multiplexed enzymatic chemistries and optical and aptamer-based platforms are being developed to expand analyte panels, while implantable sensors aim at multi-month wear. Accuracy across analytes, sensor lifetime, regulatory pathways for non-glucose analytes, clinical evidence for outcome benefit and manufacturing scale-up determine timing and pricing.
North America and Europe lead development and initial launches, with China, India and Australia contributing innovators and rapidly growing demand. Competition involves glucose monitoring incumbents, microneedle sensor start-ups and implantable and optical sensing specialists.
The InsightAce study supplies US$ forecasts for all analyte combination, sensor platform, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Multi-Analyte Continuous Metabolic Sensing Market Snapshot
Chapter 4. Global Multi-Analyte Continuous Metabolic Sensing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Analyte Combination Estimates & Trend Analysis
5.1. Analyte Combination & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Analyte Combination:
5.2.1. Glucose and Ketone Sensors
5.2.2. Glucose and Lactate Sensors
5.2.3. Multi-Analyte Panels (Glucose, Ketones, Lactate, Alcohol and Others)
5.2.4. Implantable Long-Duration Multi-Analyte Sensors
Chapter 6. Market Segmentation 2: By Sensor Platform Estimates & Trend Analysis
6.1. Sensor Platform & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Sensor Platform:
6.2.1. Enzymatic Electrochemical Microneedle and Filament Sensors
6.2.2. Optical and Fluorescence-Based Sensors
6.2.3. Emerging Non-Enzymatic and Aptamer-Based Platforms
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Diabetes Management and Diabetic Ketoacidosis Prevention
7.2.2. Sports Performance and Metabolic Training
7.2.3. Critical Care and Clinical Monitoring
7.2.4. Metabolic Wellness and Nutrition
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Endocrinology Clinics
8.2.2. Home Users and Consumers
8.2.3. Sports and Research Organizations
Chapter 9. Multi-Analyte Continuous Metabolic Sensing Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.2. Dexcom, Inc.
11.3. Medtronic plc (Medtronic Diabetes)
11.4. Sibionics (Shenzhen Sibionics Technology Co., Ltd.)
11.5. PercuSense, Inc.
11.6. Allez Health, Inc.
11.7. Biolinq Incorporated
11.8. Glucotrack, Inc.
11.9. Infinovo Medical Co., Ltd.
11.10. Know Labs, Inc.
11.11. Senseonics Holdings, Inc.
11.12. Nutromics Pty Ltd.
11.13. IDRO Sensors
11.14. Roche Diabetes Care
11.15. Nemaura Medical Inc.
圖表清單 List of Tables & Figures
Table 1. Global Multi-Analyte Continuous Metabolic Sensing Market Revenue Forecast by Analyte Combination, 2026-2035 (US$ Mn)
Figure 1. Global Multi-Analyte Continuous Metabolic Sensing Market Segmentation and Scope Overview
Table 2. Global Multi-Analyte Continuous Metabolic Sensing Market Revenue Forecast by Sensor Platform, 2026-2035 (US$ Mn)
Figure 2. Global Multi-Analyte Continuous Metabolic Sensing Market Share by Analyte Combination, 2026 & 2035
Table 3. Global Multi-Analyte Continuous Metabolic Sensing Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Multi-Analyte Sensor Pipeline by Analyte Combination, Platform and Expected Launch Window
Table 4. Global Multi-Analyte Continuous Metabolic Sensing Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Clinical and Performance Use Cases for Continuous Ketone and Lactate Monitoring
Table 5. Global Multi-Analyte Continuous Metabolic Sensing Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Multi-Analyte Continuous Metabolic Sensing Growth Opportunity Analysis
Table 6. North America Multi-Analyte Continuous Metabolic Sensing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Multi-Analyte Continuous Metabolic Sensing Market Participants
Table 7. Europe Multi-Analyte Continuous Metabolic Sensing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Multi-Analyte Continuous Metabolic Sensing Market
Table 8. Asia Pacific Multi-Analyte Continuous Metabolic Sensing Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Sensor Platform Technologies Enabling Multiplexed Continuous Measurement
Table 9. Strategic Developments of Leading Multi-Analyte Continuous Metabolic Sensing Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們